Saba Capital Management, L.P. bought HQL
June 7, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 3,763 shares of Abrdn Life Sciences Investors at $13.72 per share, a transaction worth $51.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,763
Price
$13.72
Total value
$51.6K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 7, 2024
Filing dateJune 10, 2024
Shares owned after3,393,469
OwnershipIndirect
10b5-1 planNo
AmendedNo